These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The identification of renal cell carcinoma as a target for allogeneic based cancer immunotherapy. Childs RW; Igarashi T Exp Nephrol; 2002; 10(3):227-34. PubMed ID: 12053124 [TBL] [Abstract][Full Text] [Related]
11. Allogeneic stem cell transplantation as immunotherapy for renal cell carcinoma: from immune enhancement to immune replacement. Drachenberg D; Childs RW Urol Clin North Am; 2003 Aug; 30(3):611-22. PubMed ID: 12953759 [TBL] [Abstract][Full Text] [Related]
12. Clinical responses following nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma are associated with expansion of CD8+ IFN-gamma-producing T cells. Harlin H; Artz AS; Mahowald M; Rini BI; Zimmerman T; Vogelzang NJ; Gajewski TF Bone Marrow Transplant; 2004 Mar; 33(5):491-7. PubMed ID: 14716341 [TBL] [Abstract][Full Text] [Related]
13. Allogeneic stem cell transplantation for the treatment of advanced solid tumors. Bregni M; Bernardi M; Ciceri F; Peccatori J Springer Semin Immunopathol; 2004 Nov; 26(1-2):95-108. PubMed ID: 15378271 [TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens. Tykodi SS; Warren EH; Thompson JA; Riddell SR; Childs RW; Otterud BE; Leppert MF; Storb R; Sandmaier BM Clin Cancer Res; 2004 Dec; 10(23):7799-811. PubMed ID: 15585611 [TBL] [Abstract][Full Text] [Related]
15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
16. Relationship between tumor-infiltrating T lymphocytes and clinical response after reduced-intensity allogeneic hematopoietic stem cell transplantation for advanced renal cell carcinoma: a single center prospective study. Ishiyama K; Takami A; Suzuki S; Konaka H; Namiki M; Ooi A; Nakao S Jpn J Clin Oncol; 2009 Dec; 39(12):807-12. PubMed ID: 19770130 [TBL] [Abstract][Full Text] [Related]
17. Allogeneic hematopoietic cell transplantation as immunotherapy for solid tumors: current status and future directions. Lundqvist A; Childs R J Immunother; 2005; 28(4):281-8. PubMed ID: 16000944 [TBL] [Abstract][Full Text] [Related]